Published in Cell Tissue Res on October 09, 2015
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 7.47
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91
Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg (2007) 4.00
Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol (2011) 3.65
Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal (2011) 3.31
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood (2006) 3.16
The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg (2004) 3.14
Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) (2005) 3.00
Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells (2009) 2.71
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res (2010) 2.46
Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy (2003) 2.28
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec (2001) 2.18
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol (2014) 2.00
Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med (2012) 1.92
Tissue engineered fetal skin constructs for paediatric burns. Lancet (2005) 1.92
Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res (2010) 1.73
The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns--a pilot study. Burns (2007) 1.58
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far? Immunol Cell Biol (2012) 1.43
Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction. Aesthetic Plast Surg (2008) 1.39
New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med (2007) 1.39
Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen (2010) 1.38
Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev (2010) 1.33
Scar formation: the spectral nature of fetal and adult wound repair. Plast Reconstr Surg (1996) 1.31
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells (2014) 1.29
Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells. Wound Repair Regen (2009) 1.29
Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev (2005) 1.28
The life and fate of mesenchymal stem cells. Front Immunol (2014) 1.27
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci (2011) 1.20
Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol (2010) 1.20
First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med (2005) 1.14
Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol (2008) 1.14
Tissue-engineered skin containing mesenchymal stem cells improves burn wounds. Artif Organs (2008) 1.03
Higher numbers of autologous fibroblasts in an artificial dermal substitute improve tissue regeneration and modulate scar tissue formation. J Pathol (2000) 1.02
Porcine wound models for skin substitution and burn treatment. Biomaterials (2004) 1.00
Dermal substitution in acute burns and reconstructive surgery: a 12-year follow-up. Plast Reconstr Surg (2010) 1.00
Cellular and Molecular Characteristics of Scarless versus Fibrotic Wound Healing. Dermatol Res Pract (2010) 0.97
Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogenesis (2013) 0.96
A review of fetal scarless healing. ISRN Dermatol (2012) 0.96
Rasch analysis of the Patient and Observer Scar Assessment Scale (POSAS) in burn scars. Qual Life Res (2011) 0.95
The suitability of cells from different tissues for use in tissue-engineered skin substitutes. Arch Dermatol Res (2002) 0.95
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A (2014) 0.95
Skin replacement with a collagen based dermal substitute, autologous keratinocytes and fibroblasts in burn trauma. Burns (2003) 0.89
Development, characterization, and use of a fetal skin cell bank for tissue engineering in wound healing. Cell Transplant (2006) 0.88
Collagen cross-linking by adipose-derived mesenchymal stromal cells and scar-derived mesenchymal cells: Are mesenchymal stromal cells involved in scar formation? Wound Repair Regen (2009) 0.87
Whole-cell bioprocessing of human fetal cells for tissue engineering of skin. Skin Pharmacol Physiol (2009) 0.87
Skin wound healing and scarring: fetal wounds and regenerative restitution. Birth Defects Res C Embryo Today (2012) 0.87
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis. Stem Cells (2014) 0.86
Fetal skin possesses the ability to regenerate completely: complete regeneration of skin. Keio J Med (2012) 0.85
Effect of pore size and cross-linking of a novel collagen-elastin dermal substitute on wound healing. J Mater Sci Mater Med (2013) 0.84
Current issues regarding skin substitutes using living cells as industrial materials. J Artif Organs (2007) 0.82
Activation and differentiation of mesenchymal stem cells. Methods Mol Biol (2011) 0.81
An overview of methods for the in vivo evaluation of tissue-engineered skin constructs. Tissue Eng Part B Rev (2010) 0.81
Effects of human bone marrow mesenchymal stem cells on burn injury healing in a mouse model. Int J Clin Exp Pathol (2013) 0.81
Use of mesenchymal stem cells for cutaneous repair and skin substitute elaboration. Pathol Biol (Paris) (2014) 0.80
Characterization of fetal keratinocytes, showing enhanced stem cell-like properties: a potential source of cells for skin reconstruction. Stem Cell Reports (2014) 0.78
Isolation and characterization of multipotent cells from human fetal dermis. Cell Transplant (2013) 0.77
Skin construct or biological bandage? Lancet (2005) 0.76
Currently known risk factors for hypertrophic skin scarring: A review. J Plast Reconstr Aesthet Surg (2015) 0.76